Eiko Lifesciences has informed that based on the recommendation of the Audit Committee, the Board of Directors of the Company has at its Meeting held today i.e. on 26th May, 2026, has approved the appointment of NP Rajput & Co as Internal Auditor for FY 2026-27. Disclosure of information pursuant to Regulation 30 read with Schedule III of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, and with SEBI Circular No. HO/49/14/14(7)2025-CFD-POD2/1/3762/2026 dated January 30, 2026 (‘SEBI Circular’) is attached as Annexure-A.
The above information is a part of company’s filings submitted to BSE.